Cargando…

Genetic Adjuvantation of Recombinant MVA with CD40L Potentiates CD8 T Cell Mediated Immunity

Modified vaccinia Ankara (MVA) is a safe and promising viral vaccine vector that is currently investigated in several clinical and pre-clinical trials. In contrast to inactivated or sub-unit vaccines, MVA is able to induce strong humoral as well as cellular immune responses. In order to further impr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lauterbach, Henning, Pätzold, Juliane, Kassub, Ronny, Bathke, Barbara, Brinkmann, Kay, Chaplin, Paul, Suter, Mark, Hochrein, Hubertus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753717/ https://www.ncbi.nlm.nih.gov/pubmed/23986761 http://dx.doi.org/10.3389/fimmu.2013.00251

Ejemplares similares

CD70 encoded by modified vaccinia virus Ankara enhances CD8 T‐cell‐dependent protective immunity in MHC class II‐deficient mice
por: Bathke, Barbara, et al.
Publicado: (2018)

NLRC4 Inflammasome-Driven Immunogenicity of a Recombinant MVA Mucosal Vaccine Encoding Flagellin
por: Sanos, Stephanie L., et al.
Publicado: (2018)

Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodies
por: Medina-Echeverz, José, et al.
Publicado: (2019)

Immune Requirements of Post-Exposure Immunization with Modified Vaccinia Ankara of Lethally Infected Mice
por: Lauterbach, Henning, et al.
Publicado: (2010)

Mouse CD8α(+) DCs and human BDCA3(+) DCs are major producers of IFN-λ in response to poly IC
por: Lauterbach, Henning, et al.
Publicado: (2010)

Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradication
por: Hinterberger, Maria, et al.
Publicado: (2023)

A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection
por: Endt, Kathrin, et al.
Publicado: (2022)

Intratumoral virotherapy with 4-1BBL armed modified vaccinia Ankara eradicates solid tumors and promotes protective immune memory
por: Hinterberger, Maria, et al.
Publicado: (2021)

Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis
por: Bella, Ángela, et al.
Publicado: (2022)

Adjuvants and adjuvanticity
por: Tizard, Ian R.
Publicado: (2021)

Evaluation of the Effect of CD70 Co-Expression on CD8 T Cell Response in Protein-Prime MVA-Boost Vaccination in Mice
por: Stephan, Ann-Sophie, et al.
Publicado: (2023)

Priming with a Recombinant Pantothenate Auxotroph of Mycobacterium bovis BCG and Boosting with MVA Elicits HIV-1 Gag Specific CD8(+) T Cells
por: Chapman, Rosamund, et al.
Publicado: (2012)

Protective CD8(+) T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
por: Ewer, Katie J., et al.
Publicado: (2013)

Central Role of CD169(+) Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01
por: Detienne, Sophie, et al.
Publicado: (2016)

A Critical Role for Cd40–Cd40 Ligand Interactions in Amplification of the Mucosal Cd8 T Cell Response
por: Lefrançois, Leo, et al.
Publicado: (1999)

Gene Expression Driven by a Strong Viral Promoter in MVA Increases Vaccination Efficiency by Enhancing Antibody Responses and Unmasking CD8(+) T Cell Epitope
por: Becker, Pablo D., et al.
Publicado: (2014)

The inflammasome and alum-mediated adjuvanticity
por: Kang, Suk-Jo, et al.
Publicado: (2009)

Strikingly poor CD8(+) T cell immunogenicity of vaccinia virus strain MVA in BALB/c mice
por: Russell, Tiffany A., et al.
Publicado: (2014)

Tomatine Adjuvantation of Protective Immunity to a Major Pre-erythrocytic Vaccine Candidate of Malaria is Mediated via CD8(+) T Cell Release of IFN-γ
por: Heal, Karen G., et al.
Publicado: (2010)

CD40-deficient, Influenza-specific CD8 Memory T Cells Develop and Function Normally in a CD40-sufficient Environment
por: Lee, Byung O., et al.
Publicado: (2003)

CD40–CD40L in Neurological Disease
por: Ots, Heather D., et al.
Publicado: (2022)

CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells
por: Naito, Masayasu, et al.
Publicado: (2012)

C-Rel Regulates Interleukin 12 P70 Expression in Cd8(+) Dendritic Cells by Specifically Inducing p35 Gene Transcription
por: Grumont, Raelene, et al.
Publicado: (2001)

A Soluble Version of Nipah Virus Glycoprotein G Delivered by Vaccinia Virus MVA Activates Specific CD8 and CD4 T Cells in Mice
por: Kalodimou, Georgia, et al.
Publicado: (2019)

Antigen depot is not required for alum adjuvanticity
por: Hutchison, Sharon, et al.
Publicado: (2012)

Vaccines of the Future: The Role of Inflammation and Adjuvanticity
por: Yun, Cheol-Heui, et al.
Publicado: (2015)

CD8(+) T Cells Mediate CD40-independent Maturation of Dendritic Cells In Vivo
por: Ruedl, Christiane, et al.
Publicado: (1999)

Cd40-Independent Pathways of T Cell Help for Priming of Cd8(+) Cytotoxic T Lymphocytes
por: Lu, Zhengbin, et al.
Publicado: (2000)

CD40L adjuvant for DNA/MVA vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal SIV infections
por: Kwa, S, et al.
Publicado: (2012)

Structure-Based Design of Human TLR8-Specific Agonists with Augmented Potency and Adjuvanticity
por: Beesu, Mallesh, et al.
Publicado: (2015)

Cysteine Peptidases as Schistosomiasis Vaccines with Inbuilt Adjuvanticity
por: El Ridi, Rashika, et al.
Publicado: (2014)

Innate Immune Memory: The Latest Frontier of Adjuvanticity
por: Töpfer, Elfi, et al.
Publicado: (2015)

Influence of hydrocarbon oil structure on adjuvanticity and autoimmunity
por: Yau, Anthony C. Y., et al.
Publicado: (2017)

Was bringt die adjuvante Therapie des Melanoms?
Publicado: (2022)

Deglycosylation of eukaryotic-expressed flagellin restores adjuvanticity
por: Khim, Koemchhoy, et al.
Publicado: (2023)

MyD88-dependent pro-interleukin-1β induction in dendritic cells exposed to food-grade synthetic amorphous silica
por: Winkler, Hans Christian, et al.
Publicado: (2017)

Potent CD8(+) T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA−NP+M1
por: Berthoud, Tamara K., et al.
Publicado: (2011)

CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice
por: Veit, Svenja, et al.
Publicado: (2018)

Adipocytes in their (CD)40s
por: Bertola, Adeline, et al.
Publicado: (2023)

CD40-CD40L Interaction in Immunity Against Protozoan Infections
por: Chamekh, Mustapha
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_6noms2s8mk1f3i6otmofdk38q9